Enhancing immunogenicity of DNA vaccines by targeted delivery to antigen presenting cells.
Enhancing immunogenicity of DNA vaccines by targeted delivery to antigen presenting cells.
批准号:
LP0883901
负责人:
Prof David Jackson
金额:
$5.5万
依托单位国家:
澳大利亚
项目类别:
Linkage Projects
财政年份:
2008
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2008-07-01 至 2009-12-31
中文摘要
疫苗已被证明是预防感染的最有效手段之一,也有望成为癌症的治疗方法。然而,能够提供预防多种感染的疫苗的有效技术范围有限。基于DNA的疫苗很有吸引力,因为它们相对容易生产,可以对抗多种感染。然而,DNA疫苗对感染的保护往往很差。该项目将探索澳大利亚开发的一项独特技术,该技术将大大提高DNA疫苗对多种疾病的有效性。
英文摘要
Vaccines have proven to be one of the most effective means of preventing infection and also provide promise as a treatment for cancer. However, the range of effective technologies that make possible the delivery of vaccines that can protect against a broad range of infections is limited. DNA based vaccines are attractive because they are relatively easy to produce against a wide range of infections. However, DNA vaccines often provide poor protection against infections. This project will explore a unique technology developed in Australia and that will greatly improve the effectiveness of DNA vaccines against a broad range of diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Harnessing innate immunity to mitigate bovine respiratory disease
-
批准号:DP200102090
-
项目类别:Discovery Projects
-
资助金额:$40.97万
-
财政年份:2020
-
负责人:Prof David Jackson
-
依托单位:
Enabling Technologies for Design and Delivery of Novel Vaccines Against Infectious Diseases and Cancer.
-
批准号:nhmrc : 1042018
-
项目类别:Research Fellowships
-
资助金额:$61.7万
-
财政年份:2013
-
负责人:Prof David Jackson
-
依托单位:
Heterosubtypic T cell-inducing vaccines for influenza in humans
-
批准号:nhmrc : 509299
-
项目类别:NHMRC Project Grants
-
资助金额:$23.49万
-
财政年份:2008
-
负责人:Prof David Jackson
-
依托单位:
Towards pandemic influenza vaccines
-
批准号:nhmrc : 350372
-
项目类别:NHMRC Project Grants
-
资助金额:$24.95万
-
财政年份:2005
-
负责人:Prof David Jackson
-
依托单位:
Ongoing uncoupled research fellowship
-
批准号:nhmrc : 170220
-
项目类别:NHMRC Research Fellowships
-
资助金额:$14.14万
-
财政年份:2001
-
负责人:Prof David Jackson
-
依托单位:
海外基金